Clinical Trials Browser

Phase 3 × Non-Squamous Non-Small Cell Lung Cancer × Carboplatin × Clear all

NCT00883779 2015-12-14

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3 Completed

451 enrolled 23 charts

Non-Squamous Non-Small Cell Lung Cancer